HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 6, 3900-3905, February 6, 2004

This Article Abstract Full Text (PDF) All Versions of this Article: 279/6/3900    most recent M311165200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thevissen, K. Articles by Cammue, B. P. A. Search for Related Content PubMed PubMed Citation Articles by Thevissen, K. Articles by Cammue, B. P. A. Social Bookmarking                      What's this?

Defensins from Insects and Plants Interact with Fungal Glucosylceramides^*

Karin Thevissen, Dirk C. Warnecke¶, Isabelle E. J. A. François, Martina Leipelt¶, Ernst Heinz¶, Claudia Ott¶, Ulrich Zähringer||, Bart P. H. J. Thomma**, Kathelijne K. A. Ferket, and Bruno P. A. Cammue

From the Centre of Microbial and Plant Genetics, Kasteelpark Arenberg 20, Heverlee B-3001, Belgium, the ^¶Institut für Allgemeine Botanik, University of Hamburg, Ohnhorststrasse 18, Hamburg 22609, Germany, and the ^||Research Center Borstel, Center for Medicine and Biosciences, Parkallee 22, Borstel 23845, Germany

Received for publication, October 10, 2003

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Growth of the yeast species Candida albicans and Pichia pastoris is inhibited by RsAFP2, a plant defensin isolated from radish seed (Raphanus sativus), at micromolar concentrations. In contrast, gcs-deletion mutants of both yeast species are resistant toward RsAFP2. GCS genes encode UDP-glucose:ceramide glucosyltransferases, which catalyze the final step in the biosynthesis of the membrane lipid glucosylceramide. In an enzyme-linked immunosorbent assay-based binding assay, RsAFP2 was found to interact with glucosylceramides isolated from P. pastoris but not with soybean nor human glucosylceramides. Furthermore, the P. pastoris parental strain is sensitive toward RsAFP2-induced membrane permeabilization, whereas the corresponding gcs-deletion mutant is highly resistant to RsAFP2-mediated membrane permeabilization. A model for the mode of action of RsAFP2 is presented in which all of these findings are linked. Similarly to RsAFP2, heliomicin, a defensin-like peptide from the insect Heliothis virescens, is active on C. albicans and P. pastoris parental strains but displays no activity on the gcs-deletion mutants of both yeast species. Furthermore, heliomicin interacts with glucosylceramides isolated from P. pastoris and soybean but not with human glucosylceramides. These data indicate that structurally homologous anti-fungal peptides present in species from different eukaryotic kingdoms interact with the same target in the fungal plasma membrane, namely glucosylceramides, and as such support the hypothesis that defensins from plants and insects have evolved from a single precursor.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Innate immunity is an ancient defense strategy used by multicellular organisms to control the natural flora and combat pathogens. This strategy involves, among other responses, the production of cationic antimicrobial peptides (AMPs)¹ that generally have a broad activity spectrum. Until now, only one class of AMPs is found to be conserved among plants, invertebrates, and vertebrates, namely defensins. Defensins are small, highly basic cysteine-rich peptides that share a common three-dimensional structure (for review, see Ref. 1). The global fold of plant defensins comprises a cysteine-stabilized motif consisting of an -helix and a triple-stranded -sheet, organized in a architecture and stabilized by four disulfide bridges. Most plant defensins possess antifungal or antibacterial activity in vitro but are noncytotoxic to either mammalian or plant cells. Insect defensins combine an -helix and a double-stranded -sheet stabilized by three disulfide bridges, organized in a cysteine-stabilized motif as found in plant defensins (2, 3). An even higher homology to plant defensins is found for the insect defensin-like peptide heliomicin, which carries a triple-stranded -sheet in a fold forming a cysteine-stabilized motif (4). In addition to similarities in their global folds, heliomicin and the radish plant defensin RsAFP2 exhibit very similar distributions of hydrophobic residues (4) and display similar biological activities: both peptides are antifungal rather than antibacterial (5, 6).

Most cationic antimicrobial peptides induce membrane permeabilization after initial electrostatic binding to negatively charged phospholipids on the target cell surface. In contrast, plant defensins induce membrane permeabilization through specific interaction with high affinity binding sites on fungal cells (7–9). Via a genetic complementation approach, IPT1 was identified as a gene determining sensitivity toward the dahlia plant defensin Dm-AMP1 in Saccharomyces cerevisiae (10). IPT1 encodes an enzyme involved in the last step of the synthesis of the sphingolipid mannosyldiinositolphosphorylceramide (M(IP)₂C) (11). Strains with a nonfunctional IPT1 allele lacked M(IP)₂C in their membranes bound significantly less DmAMP1 compared with the parental S. cerevisiae strain and were highly resistant to DmAMP1-induced membrane permeabilization. Possibly, membrane patches containing sphingolipids act as binding sites for DmAMP1. Interaction between DmAMP1 and these sphingolipids could lead to insertion of the plant defensin into the membrane resulting in membrane destabilization (10, 12).

In the yeast S. cerevisiae, the main sphingolipids are (mannosylated) inositolphosphorylceramides (namely IPC, MIPC, and M(IP)₂C). There is growing evidence that fungi maintain two separate pools of ceramides to be used for the synthesis of different sphingolipids (13–15). Ceramide backbones with very long chain C₂₄ and C₂₆ fatty acids bound to the sphingobase 4-hydroxysphinganine are directed to the synthesis of the inositolphosphoryl-containing sphingolipids (Fig. 1A), whereas ceramide backbones with C₁₆ or C₁₈ fatty acids linked to the sphingobase 9-methyl-4,8-sphingadienine are exclusively used as precursors for biosynthesis of glucosylceramide (GlcCer) (Fig. 1B). GlcCer have never been found in S. cerevisiae under various culture conditions (16). This is in contrast with many fungal and yeast species in which both inositolphosphoryl-containing sphingolipids and significant amounts of GlcCer have been detected (17, 18).

View larger version (28K): [in this window] [in a new window]   FIG. 1. Structure of M(IP)2C (A) and GlcCer (B). The sphingobase moiety is boxed.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Materials and Microorganisms—The antifungal peptides DmAMP1, RsAFP2, and RsAFP2(Y38G) were isolated as described previously (6, 20, 21). Nonimmune and anti-RsAFP2 sera from rabbit were used as described previously (6). Heliomicin and anti-heliomicin rabbit anti-serum were kindly provided by Dr. P. Bulet (Institut de Biologie Moléculaire et Cellulaire, CNRS, Strasbourg, France) and Dr. J. L. Dimarcq (Entomed, Strasbourg, France), respectively. Anti-GlcCer serum from rabbit (22) was kindly provided by Dr. L. Brade (Research Center Borstel, Center for Medicine and Biosciences, Borstel, Germany). Ergosterol, phosphatase-coupled goat anti-rabbit immunoglobulins, and GlcCer isolated from human (Gaucher's spleen) were purchased from Sigma. GlcCer isolated from soybean was purchased from Avanti Polar Lipids (Alabaster, AL). SYTOX Green was obtained from Molecular Probes (Eugene, OR). Yeast strains used in this study are S. cerevisiae strain BY4741 (Invitrogen), P. pastoris strain GS115 (Invitrogen) and the corresponding P. pastoris gcs-deletion strain (13), C. albicans strain SC5314 CAI4 (23) and the corresponding C. albicans gcs-deletion strain (13).

Antifungal Activity Assay—Antifungal activity of protein samples against yeast strains was assayed by microscopic analysis of liquid cultures grown in microtiter plates as described previously (8–10). Growth medium used was either PDB (24 g/liter potato dextrose broth, Sigma) or PDB/YPD (24 g/liter PDB; 2 g/liter yeast extract, Difco; 4 g/liter Peptone, Difco; 4 g/liter glucose) supplemented with 50 mM HEPES, pH 7.0. The antagonistic effect of either antisera or RsAFP2(Y38G) on the antifungal activity of RsAFP2 was assayed by incubating 10 µl of an overnight P. pastoris culture in 1 ml of fresh PDB/YPD, pH 7.0, in the presence of either the antagonizing compound or distilled water. After 30 min of preincubation, the antifungal activity of RsAFP2 on these P. pastoris cultures was assayed as described above.

SYTOX Green Uptake—Cells of an overnight culture of P. pastoris in PDB/YPD were incubated with RsAFP2 or 0.5% SDS in PDB/YPD, pH 7.0, for 2 h. After incubation, cells were washed with SMF1 (9) supplemented with 0.25 µM SYTOX Green and 50 mM HEPES, pH 7.0. Hundred-µl aliquots of this cell suspension were incubated with RsAFP2 in white 96-well microtiter plates (PE white; PerkinElmer Life Sciences) for 2 h at room temperature, after which the fluorescence was measured as described previously (9). Membrane permeabilization induced by 0.5% SDS corresponds to 100% membrane permeabilization.

Purification, Quantification, and Analysis of GlcCer—Purification of GlcCer from P. pastoris was performed as described previously (16). GlcCer from soybean and from human (Gaucher's) spleen were purchased from Avanti Polar Lipids and Sigma, respectively. Monogalactosyldiacylglycerol was purified from a crude lecithin fraction from soybean (Glycine max) by thin-layer chromatography (TLC). The purity of the lipids was confirmed by TLC and by straight phase HPLC (data not shown). Quantification of the glycolipids was performed by the anthrone method (24). Sphingobase composition of GlcCer from P. pastoris and soybean were analyzed by HPLC and HPLC/MS after hydrolysis of the GlcCer and conversion of the sphingobases into 2,4-dinitrophenol derivatives as described previously (25). The fatty acid composition of the GlcCer was determined by GLC/MS. Total fatty acid analysis of GlcCer was performed with 200-µg aliquots after methanolysis (1.5 ml of 2 M HCl/MeOH, 85 °C, 1 h) in sealed ampoules. The methanolyzed samples were dissolved in water, and the resulting fatty acid methyl esters were extracted three times with 3 ml of chloroform, concentrated to dryness, acetylated with 1 ml of pyridine/acetic anhydride (2:1, v/v; 80 °C, 1 h) concentrated, and analyzed by GLC/MS. GLC/MS analysis was performed with a HP-5MS column (30 m, Hewlett Packard) using a temperature gradient from 150 °C (3 min) to 320 °C at 5 °C min^–1. EI and CI mass spectra were recorded as described previously (26).

Microtiter Plate Binding Assay (ELISA)—Interaction of antifungal peptides with GlcCer was evaluated by using an ELISA-based assay as described previously (27–30). Stock solutions of all glycolipids were prepared in methanol:chloroform:water (16:16:5, v/v/v) at a concentration of 500 µM. Lipids were applied in 75-µl aliquots to the wells of microtiter plates and allowed to dry overnight at room temperature. All subsequent handling steps were performed at 37 °C. Blocking buffer was 1% (w/v) gelatin (cold fish skin, Sigma) in phosphate-buffered saline, and washing buffer was 10% blocking buffer. Anti-RsAFP2 and anti-heliomicin rabbit antiserum and phosphatase-coupled goat anti-rabbit immunoglobulin were 1,000-fold diluted in washing buffer. Plotted values are means of triplicates adjusted for the plate background. Plate background values are the absorbance readings of methanol: chloroform:water (16:16:5, v/v/v)-coated wells incubated with peptides and antisera.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
P. pastoris and C. albicans Mutant Strains Lacking GlcCer Are Resistant to RsAFP2—To investigate a possible role of GlcCer in RsAFP2-mediated growth inhibition, mutants of P. pastoris and C. albicans which are completely devoid of GlcCer were used (13). The gcs-deletion mutants and their corresponding parental strains were tested for sensitivity to growth inhibition by RsAFP2. C. albicans and P. pastoris are sensitive to RsAFP2 at concentrations of 1–2 µM and higher, whereas the corresponding gcs-deletion strains are at least 20-fold more resistant to RsAFP2 (Table I). To test whether the GCS gene is also involved in conferring sensitivity toward other plant defensins, the gcs-deletion strains and the corresponding parental strains were tested for sensitivity to growth inhibition by dahlia plant defensin DmAMP1. DmAMP1 is equally active on both gcs-deletion mutants and the corresponding parental strains (Table I). The involvement of GlcCer in the process leading to fungal growth inhibition by RsAFP2 was supported further by the observation that S. cerevisiae and Schizosaccharomyces pombe, two yeast species that lack GlcCer in their membranes (16, 18), are fully resistant to RsAFP2 (Table I). To examine further the involvement of GlcCer in RsAFP2 activity, we envisaged to test RsAFP2 sensitivity of a S. cerevisiae strain expressing an heterologous GCS gene (13). However, GlcCer analysis of such S. cerevisiae strains showed the presence of novel types of GlcCer components, consisting of a 4-hydroxysphinganine and a very long chain fatty acid (C₂₄ or C₂₆) (13). GlcCer consisting of the characteristic 4,8-diunsaturated, C9-methyl-branched sphingobase linked to a long chain fatty acid (C₁₆ or C₁₈), as present in membranes of P. pastoris and C. albicans (Fig. 2 and Table II) (16), could not be detected in such GCS-expressing S. cerevisiae strains, which makes this approach unfeasible.

View larger version (17K): [in this window] [in a new window]   FIG. 2. Sphingobase composition of GlcCer from soybean meal and P. pastoris. GlcCer was purified from lipid extracts of the two organisms and hydrolyzed. The released sphingobases were transformed into their 2,4-dinitrophenol derivatives and analyzed by HPLC. The designations trans or cis refer to the double bonds at the C-8 position. The double bonds at C-4 are always in trans configuration.

4

,8

4

,8

4

,8

4

Using the ELISA-based binding assay, RsAFP2 was found to interact in a dose-dependent manner with purified GlcCer from P. pastoris (Fig. 3A). No significant interaction of RsAFP2 with different concentrations of neither human or soybean GlcCer or with soybean monogalactosyldiacylglycerols could be detected, indicating that RsAFP2 interacts selectively with P. pastoris GlcCer.

View larger version (17K): [in this window] [in a new window]   FIG. 3. Interaction of RsAFP2 and heliomicin with GlcCer. Dose-response curves are presented for the interaction of RsAFP2 (A) and heliomicin (B) with GlcCer from P. pastoris (squares), human spleen (triangles), soybean (diamonds), and monogalactosyldiacylglycerols from soybean (circles). RsAFP2 and heliomicin were used at a concentration of 50 nM. Data are the means ± S.E. of triplicates.

Link between the Antifungal Activity of RsAFP2 and Its Interaction with Fungal GlcCer—To address the link between the antifungal activity of RsAFP2 and its interaction with fungal GlcCer, the interaction of an RsAFP2 variant that is devoid of antifungal activity (RsAFP2(Y38G)) (21) with fungal GlcCer was assessed. Similarly to RsAFP2, RsAFP2(Y38G) interacts with GlcCer from P. pastoris, but not with GlcCer from human origin (Fig. 4). These results indicate that RsAFP2(Y38G) is competent for GlcCer binding but is impaired in the induction of fungal growth inhibition. Hence, interaction of RsAFP2 with fungal GlcCer is not sufficient to induce fungal growth arrest. Based on this observation, it could be anticipated that P. pastoris cells pretreated with RsAFP2(Y38G) should be more resistant to subsequent treatment with RsAFP2. Therefore, we investigated a putative antagonism between RsAFP2(Y38G) and RsAFP2 by preincubating P. pastoris cells with either 40 µM RsAFP2(Y38G) or water and assessing the sensitivity of the preincubated P. pastoris cells to RsAFP2. The antifungal activity of RsAFP2 was not affected by the presence of RsAFP2(Y38G). The MIC value of RsAFP2 was the same in the absence or presence of RsAFP2(Y38G) (MIC = 2 µM). Hence, no antagonism between RsAFP2(Y38G) and RsAFP2 was observed. This can be explained by the finding that some plant defensins bind reversibly to fungal and yeast cells (7). In this respect, it is possible that RsAFP2(Y38G), which does not display antifungal activity and therefore probably cannot reach and/or affect the fungal target, can be displaced from its primary binding site by RsAFP2. Hence, this approach is not appropriate to demonstrate the link between the antifungal activity of RsAFP2 and its interaction with fungal GlcCer.

View larger version (27K): [in this window] [in a new window]   FIG. 4. Interaction of an inactive variant of RsAFP2 with fungal GlcCer. The interaction of 50 nM RsAFP2 (white bars) or the biologically inactive variant RsAFP2(Y38G) (gray bars) with GlcCer from P. pastoris and human spleen is presented. Each microtiter plate well was coated with 0.5 nmol of each glycolipid. Data are the means ± S.E. of triplicates.

RsAFP2 Induces Permeabilization of P. pastoris Cells but Not of the Corresponding gcs-Deletion Mutant—To determine the role of GlcCer in RsAFP2-mediated membrane permeabilization of yeast cells, an assay based on the uptake of SYTOX Green was used (9). SYTOX Green is an organic compound that only penetrates cells with compromised plasma membranes and fluoresces upon interaction with nucleic acids (33). RsAFP2-induced SYTOX Green uptake was assessed in P. pastoris parental strain and the corresponding gcs-deletion mutant. SYTOX Green uptake in the P. pastoris parental strain increases significantly upon treatment with RsAFP2 at concentrations higher than 2 µM (Fig. 5). No such RsAFP2-induced membrane permeabilization can be detected in the gcs-deletion mutant up to 10 µM. However, a minor increase of permeabilization in the gcs-deletion mutant was observed for RsAFP2 concentrations higher than 10 µM, consistent with previously observed DmAMP1-induced permeabilization of the S. cerevisiae parental strain and a DmAMP1-resistant ipt1 mutant (9). Plant defensin-induced permeabilization occurring at high plant defensin concentrations (10–40 µM) is proposed to result from an interaction of the peptides with the membrane in a binding site-independent manner (9).

View larger version (20K): [in this window] [in a new window]   FIG. 5. RsAFP2-induced membrane permeabilization of P. pastoris parental strain but not of the gcs-deletion mutant. RsAFP2-induced membrane permeabilization was measured by SYTOX Green uptake of parental strain of P. pastoris (black squares) and the gcs-deletion mutant (white squares). Pretreated yeast cells suspended in SMF1 were incubated in the presence of different concentrations of RsAFP2 for 2 h, after which fluorescence was measured. Data are the means ± S.E. of duplicates.

The Insect Defensin-like Peptide Heliomicin Interacts with the Same Fungal Target as RsAFP2—The three-dimensional structure of heliomicin, an insect defensin-like peptide from the lepidopteran Heliothis virescens, is highly homologous to radish plant defensin RsAFP2 (1, 4). In addition, both peptides display similar biological activities. Therefore, a possible involvement of fungal GlcCer in heliomicin-induced antifungal activity was assessed. As observed for RsAFP2, growth of C. albicans and P. pastoris is inhibited by heliomicin starting from 2 µM, whereas gcs-deletion mutants of both yeast strains are at least 20-fold more resistant (Table I). In addition, heliomicin was found to interact with fungal GlcCer in a dose-dependent manner, but not with human GlcCer or soybean monogalactosyldiacylglycerols (Fig. 3B). In contrast to RsAFP2, however, heliomicin also interacts with soybean GlcCer.

Furthermore, the ability of RsAFP2 to compete with heliomicin for P. pastoris GlcCer interaction was tested. Interaction of heliomicin with P. pastoris GlcCer cannot be competed for by a 50-fold excess of RsAFP2 and vice versa (results not shown), indicating that heliomicin and RsAFP2 are probably interacting with different motifs of the fungal GlcCer.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
In this study, we present clear evidence that the radish antifungal defensin RsAFP2 and the highly homologous insect defensin-like peptide heliomicin both interact directly with fungal GlcCer. We have discussed previously the evolutionary conservation of defensins among different kingdoms of eukaryotes (1). Based on a comparison of their overall three-dimensional structure, there is a close relationship among plant defensins, insect defensins, and mammalian -defensins. In some cases this "interkingdom" structural homology is even stronger than the structural homology among different types of defensins from the same species, such as mammalian - and -defensins (1). This suggests that defensins are ancient peptides conserved across the eukaryotic kingdom, originating before the evolutionary divergence of plants and animals. Possibly, defensins have evolved from a single precursor, being a molecule with an overall structure resembling that of plant defensins. Evidence presented in this paper substantiates this hypothesis further, as a plant defensin and an insect defensin-like peptide both interact with conserved binding sites on susceptible fungi, namely GlcCer. To our knowledge, this is the first demonstration that related defense components from organisms belonging to different kingdoms target the same microbial structure.

The interaction of RsAFP2 with fungal GlcCer was found to be selective because RsAFP2 did not interact with human or plant GlcCer nor with plant monogalactosyldiacylglycerols. Differences in ceramide structure among fungal, plant, and human GlcCer probably account for the observed binding selectivity. GlcCer from various fungal and yeast species, such as P. pastoris (16), C. albicans (19), Lentinus edodes (34), Pseudallescheria boydii (35) and Cryptococcus neoformans (36, 37), are identical (Glc-9-methyl-d18:2/h18:0 = N-2'-hydroxyoctadecanoyl-1-O--D-glucopyranosyl-(4E,8E)-9-methylsphinga-4,8-dienine) (17). Fungal GlcCer show a number of structural features that distinguish them from those found in mammals and plants, such as the 9-methyl group branching of the sphingoid base, variable levels of unsaturation and length of the fatty acid chain. The exact structural features of fungal GlcCer which are important for the interaction with the antifungal defensins and/or subsequent cell growth inhibition are currently being assessed via a genetic deletion approach in P. pastoris and ELISA-based binding studies of the corresponding GlcCer. The finding that heliomicin, in contrast to RsAFP2, interacts with fungal and plant GlcCer points toward different GlcCer-interacting characteristics for RsAFP2 and heliomicin. This is also reflected by the observation that interaction of heliomicin with fungal GlcCer could not be competed for by RsAFP2 and vice versa, indicating that heliomicin and RsAFP2 probably interact with different structural motifs of the fungal GlcCer.

Previously, we demonstrated that RsAFP2 induces membrane permeabilization in susceptible fungi (9). In this study, we show that RsAFP2 induces membrane permeabilization in a susceptible P. pastoris yeast strain at concentrations higher than 2 µM. In contrast, no such RsAFP2-induced membrane permeabilization was detected in the RsAFP2-resistant P. pastoris gcs-deletion mutant. Hence, it can be concluded that the GCS gene determines RsAFP2-induced permeabilization. Our findings that fungal GlcCer constitute the RsAFP2 binding site and that the GCS gene determines RsAFP2-induced permeabilization as well as fungal growth inhibition provide strong support for a model in which all of these phenomena are causally linked. We propose a two-step model for the mode of action of RsAFP2, i.e. 1) interaction of RsAFP2 with GlcCer in the fungal plasma membrane (as evidenced by this study) and 2) subsequent permeabilization of the fungal plasma membrane (as demonstrated previously (9)). The finding that RsAFP2(Y38G), an RsAFP2 variant devoid of antifungal activity (21), still interacts to the same extent with fungal GlcCer as native RsAFP2, confirms the hypothesized two-step model for the mode of action of RsAFP2. Indeed, it seems that the mutant RsAFP2(Y38G) is competent for GlcCer binding but is impaired in induction of membrane permeabilization and fungal growth inhibition. In this study, we furthermore demonstrated that antibodies against GlcCer could antagonize the antifungal activity of RsAFP2 by blocking its target on the fungal plasma membrane, namely GlcCer, thereby providing a link between the observed interaction of RsAFP2 with fungal GlcCer on one hand and inhibition of fungal growth on the other hand. Based on these observations, we can conclude that interaction of RsAFP2 with fungal GlcCer is not sufficient but necessary to induce fungal growth arrest. This conclusion is also supported by the finding that heliomicin does not seem to be phytotoxic (41), although it interacts with GlcCer from plants.

The composition of the plasma membrane of fungal cells is asymmetric, which is typical of eukaryotic cells, with phosphatidylserine mainly in the inner leaflet and sterols and sphingolipids in the outer leaflet (38). It has been shown that sphingolipids and sterols are enriched in specific domains in the plasma membranes, the so-called membrane rafts (31, 32). We demonstrated recently that the interaction between the dahlia plant defensin DmAMP1 and inositolphosphoryl-containing sphingolipids from S. cerevisiae is enhanced by 40% in the presence of equimolar concentrations of ergosterol (12), pointing toward a putative involvement of rafts in the DmAMP1 interaction with the fungal plasma membrane. This is in contrast to the interaction between RsAFP2 and fungal GlcCer, which is not altered by different concentrations of ergosterol.

Most antimicrobial peptides studied thus far are known to interact with ubiquitous phospholipids via a charge-based mechanism, explaining their relatively broad antimicrobial spectrum. Fungal GlcCer have not been identified so far as possible targets for antimicrobial peptides. However, verotoxins, a family of related AB5 toxins produced by Escherichia coli, have been shown to bind to the mammalian glycosphingolipid globotriaosyl ceramide (Glb₃) (28, 42, 43). Globotriaosyl ceramide (Gal(1–4)-Gal(1–4)-Glc1-ceramide) is differentially organized in glycolipid-enriched microdomains in mammalian membranes (44). After internalization of the holotoxin by receptor-mediated endocytosis, verotoxin inhibits protein synthesis resulting in necrosis and/or apoptosis (45–47). Whether RsAFP2-induced fungal growth arrest is a result of the induced membrane permeabilization or results from its interaction with a putative intracellular target is currently not known. Several plant defensins isolated from barley have been shown to inhibit protein synthesis in eukaryotic as well as prokaryotic cell-free systems (39, 40), supporting the theory of intracellular targets for plant defensins. Studies are currently initiated to address the subcellular localization of fluorescently labeled RsAFP2 in susceptible yeast cells and as such to provide crucial information regarding such putative intracellular RsAFP2 targets. In this respect, the RsAFP2-resistant gcs-deletion mutants characterized in this study are considered invaluable tools.

	FOOTNOTES

 
^* This work was supported in part by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 470, and by the BMBF Project NAPUS 2000 Part 0312252F. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^** Postdoctoral fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. Present address: Laboratory of Phytopathology, Wageningen University, The Netherlands.

To whom correspondence should be addressed. Tel.: 32-16-32-9688; Fax: 32-16-32-1966; E-mail: karin.thevissen{at}agr.kuleuven.ac.be.

¹ The abbreviations used are: AMP, antimicrobial peptide; AFP, antifungal peptide; ELISA, enzyme-linked immunosorbent assay; GLC, gas-liquid chromatography; GlcCer, glucosylceramide(s); HPLC, high performance liquid chromatography; M(IP)₂C, mannosyldiinositolphosphorylceramide; MS, mass spectrometry.

	ACKNOWLEDGMENTS

 
We thank Drs. J. L. Dimarcq (Entomed, Strasbourg, France) and P. Bulet (Institut de Biologie Moléculaire et Cellulaire, CNRS, Strasbourg, France) for heliomicin and anti-heliomicin antiserum, respectively; Dr. L. Brade for supply of anti-GlcCer serum of rabbit (Research Center Borstel, Center for Medicine and Biosciences, Borstel, Germany); Prof. W. Broekaert and Drs. M. De Bolle and I. Penninckx for critical comments; and Dr. S. Franke for support with HPLC/MS analysis. We thank W. Hellmeyer for skillful technical assistance.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Thomma, B. P. H. J., Cammue, B. P. A., and Thevissen, K. (2002) Planta 216, 193–202[CrossRef][Medline] [Order article via Infotrieve]
2. Bonmatin, J. M., Bonnat, J. L., Gallet, X., Vovelle, F., Ptak, M., Reichhart, J. M., Hoffmann, J. A., Keppi, E., Legrain, M., and Achstetter, T. (1992) J. Biomol. NMR 2, 235–256[CrossRef][Medline] [Order article via Infotrieve]
3. Cornet, B., Bonmatin, J. M., Hetru, C., Hoffmann, J. A., Ptak, M., and Vovelle, F. (1995) Structure 3, 435–448[Medline] [Order article via Infotrieve]
4. Lamberty, M., Caille, A., Landon, C., Tassin-Moindrot, S., Hetru, C., Bulet, P., and Vovelle, F. (2001) Biochemistry 40, 11995–12003[CrossRef][Medline] [Order article via Infotrieve]
5. Lamberty, M., Ades, S., Uttenweiler-Joseph, S., Brookhart, G., Bushey, D., Hoffmann, J. A., and Bulet, P. (1999) J. Biol. Chem. 274, 9320–9326[Abstract/Free Full Text]
6. Terras, F. R., Schoofs, H. M., De Bolle, M. F., Van Leuven, F., Rees, S. B., Vanderleyden, J., Cammue, B. P., and Broekaert, W. F. (1992) J. Biol. Chem. 267, 15301–15309[Abstract/Free Full Text]
7. Thevissen, K., Osborn, R. W., Acland, D. P., and Broekaert, W. F. (1997) J. Biol. Chem. 272, 32176–32181[Abstract/Free Full Text]
8. Thevissen, K., Osborn, R. W., Acland, D. P., and Broekaert, W. F. (2000) Mol. Plant Microbe Interact. 13, 54–61[Medline] [Order article via Infotrieve]
9. Thevissen, K., Terras, F. R., and Broekaert, W. F. (1999) Appl. Environ. Microbiol. 65, 5451–5458[Abstract/Free Full Text]
10. Thevissen, K., Cammue, B. P., Lemaire, K., Winderickx, J., Dickson, R. C., Lester, R. L., Ferket, K. K., Van Even, F., Parret, A. H., and Broekaert, W. F. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 9531–9536[Abstract/Free Full Text]
11. Dickson, R. C., Nagiec, E. E., Wells, G. B., Nagiec, M. M., and Lester, R. L. (1997) J. Biol. Chem. 272, 29620–29625[Abstract/Free Full Text]
12. Thevissen, K., Francois, I. E. J. A., Takemoto, J. Y., Ferket, K. K. A., Meert, E. M. K., and Cammue, B. P. A. (2003) FEMS Microbiol. Lett. 226, 169–173[CrossRef][Medline] [Order article via Infotrieve]
13. Leipelt, M., Warnecke, D., Zähringer, U., Ott, C., Müller, F., Hube, B., and Heinz, E. (2001) J. Biol. Chem. 276, 33621–33629[Abstract/Free Full Text]
14. Toledo, M. S., Levery, S. B., Straus, A. H., and Takahashi, H. K. (2000) J. Lipid Res. 41, 797–806[Abstract/Free Full Text]
15. Toledo, M. S., Levery, S. B., Suzuki, E., Straus, A. H., and Takahashi, H. K. (2001) Glycobiology 11, 113–124[Abstract/Free Full Text]
16. Sakaki, T., Zähringer, U., Warnecke, D. C., Fahl, A., Knogge, W., and Heinz, E. (2001) Yeast 18, 679–695[CrossRef][Medline] [Order article via Infotrieve]
17. Warnecke, D., and Heinz, E. (2003) Cell. Mol. Life Sci. 60, 919–941[Medline] [Order article via Infotrieve]
18. Dickson, R. C., and Lester, R. L. (1999) Biochim. Biophys. Acta 1426, 347–357[Medline] [Order article via Infotrieve]
19. Matsubara, T., Hayashi, A., Banno, Y., Morita, T., and Nozawa, Y. (1987) Chem. Phys. Lipids 43, 1–12[CrossRef][Medline] [Order article via Infotrieve]
20. Osborn, R. W., De Samblanx, G. W., Thevissen, K., Goderis, I., Torrekens, S., Van Leuven, F., Attenborough, S., Rees, S. B., and Broekaert, W. F. (1995) FEBS Lett. 368, 257–262[CrossRef][Medline] [Order article via Infotrieve]
21. De Samblanx, G. W., Goderis, I. J., Thevissen, K., Raemaekers, R., Fant, F., Borremans, F., Acland, D. P., Osborn, R. W., Patel, S., and Broekaert, W. F. (1997) J. Biol. Chem. 272, 1171–1179[Abstract/Free Full Text]
22. Brade, L., Vielhaber, G., Heinz, E., and Brade, H. (2000) Glycobiology 10, 629–636[Abstract/Free Full Text]
23. Fonzi, W. A., and Irwin, M. Y. (1993) Genetics 134, 717–728[Abstract]
24. Morris, D. L. (1948) Science 107, 254–257[Free Full Text]
25. Ternes, P., Franke, S., Zähringer, U., Sperling, P., and Heinz, E. (2002) J. Biol. Chem. 277, 25512–25518[Abstract/Free Full Text]
26. Sperling, P., Zähringer, U., and Heinz, E. (1998) J. Biol. Chem. 273, 28590–28596[Abstract/Free Full Text]
27. Mamelak, D., and Lingwood, C. (2001) J. Biol. Chem. 276, 449–456[Abstract/Free Full Text]
28. Mylvaganam, M., Binnington, B., Hansen, H. C., Magnusson, G., Nyholm, P. G., and Lingwood, C. A. (2002) Biochem. J. 368, 769–776[CrossRef][Medline] [Order article via Infotrieve]
29. Mamelak, D., Mylvaganam, M., Tanahashi, E., Ito, H., Ishida, H., Kiso, M., and Lingwood, C. (2001) Carbohydr. Res. 335, 91–100[CrossRef][Medline] [Order article via Infotrieve]
30. Toledo, M. S., Suzuki, E., Levery, S. B., Straus, A. H., and Takahashi, H. K. (2001) Glycobiology 11, 105–112[Abstract/Free Full Text]
31. Xu, X., Bittman, R., Duportail, G., Heissler, D., Vilcheze, C., and London, E. (2001) J. Biol. Chem. 276, 33540–33546[Abstract/Free Full Text]
32. Bagnat, M., Keranen, S., Shevchenko, A., Shevchenko, A., and Simons, K. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 3254–3259[Abstract/Free Full Text]
33. Roth, B. L., Poot, M., Yue, S. T., and Millard, P. J. (1997) Appl. Environ. Microbiol. 63, 2421–2431[Abstract]
34. Kawai, G., and Ikeda, Y. (1985) J. Lipid Res. 26, 338–343[Abstract]
35. Pinto, M. R., Rodrigues, M. L., Travassos, L. R., Haido, R. M., Wait, R., and Barreto-Bergter, E. (2002) Glycobiology 12, 251–260[Abstract/Free Full Text]
36. Levery, S. B., Toledo, M. S., Doong, R. L., Straus, A. H., and Takahashi, H. K. (2000) Rapid Commun. Mass Spectrom. 14, 551–563[CrossRef][Medline] [Order article via Infotrieve]
37. Rodrigues, M. L., Travassos, L. R., Miranda, K. R., Franzen, A. J., Rozental, S., de Souza, W., Alviano, C. S., and Barreto-Bergter, E. (2000) Infect. Immun. 68, 7049–7060[Abstract/Free Full Text]
38. Schneiter, R., Brugger, B., Sandhoff, R., Zellnig, G., Leber, A., Lampl, M., Athenstaedt, K., Hrastnik, C., Eder, S., Daum, G., Paltauf, F., Wieland, F. T., and Kohlwein, S. D. (1999) J. Cell Biol. 146, 741–754[Abstract/Free Full Text]
39. Mendez, E., Moreno, A., Colilla, F., Pelaez, F., Limas, G. G., Mendez, R., Soriano, F., Salinas, M., and de Haro, C. (1990) Eur. J. Biochem. 194, 533–539[Medline] [Order article via Infotrieve]
40. Mendez, E., Rocher, A., Calero, M., Girbes, T., Citores, L., and Soriano, F. (1996) Eur. J. Biochem. 239, 67–73[Medline] [Order article via Infotrieve]
41. Banzet, N., Latorse, M.-P., Bulet, P., Francois, E., Derpierre, C., and Dubald, M. (2002) Plant Sci. 162, 995–1006[CrossRef]
42. Waddell, T., Cohen, A., and Lingwood, C. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 7898–7901[Abstract/Free Full Text]
43. Lingwood, C. A. (1994) Nephron 66, 21–28[Medline] [Order article via Infotrieve]
44. Mori, T., Kiyokawa, N., Katagiri, Y. U., Taguchi, T., Suzuki, T., Sekino, T., Sato, N., Ohmi, K., Nakajima, H., Takeda, T., and Fujimoto, J. (2000) Exp. Hematol. 28, 1260–1268[CrossRef][Medline] [Order article via Infotrieve]
45. Sandvig, K., Olsnes, S., Brown, J. E., Petersen, O. W., and van Deurs, B. (1989) J. Cell Biol. 108, 1331–1343[Abstract/Free Full Text]
46. Kiyokawa, N., Taguchi, T., Mori, T., Uchida, H., Sato, N., Takeda, T., and Fujimoto, J. (1998) J. Infect. Dis. 178, 178–184[Medline] [Order article via Infotrieve]
47. Gordon, J., Challa, A., Levens, J. M., Gregory, C. D., Williams, J. M., Armitage, R. J., Cook, J. P., Roberts, L. M., and Lord, J. M. (2000) Cell Death Differ. 7, 785–794[CrossRef][Medline] [Order article via Infotrieve]
48. Sullards, M. C., Lynch, D. V., Merrill, A. H., Jr., and Adams, J. (2000) J. Mass Spectrom. 35, 347–353[CrossRef][Medline] [Order article via Infotrieve]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				V. Ramamoorthy, E. B. Cahoon, M. Thokala, J. Kaur, J. Li, and D. M. Shah Sphingolipid C-9 Methyltransferases Are Important for Growth and Virulence but Not for Sensitivity to Antifungal Plant Defensins in Fusarium graminearum Eukaryot. Cell, February 1, 2009; 8(2): 217 - 229. [Abstract] [Full Text] [PDF]

				S. Zauner, U. Zahringer, B. Lindner, D. Warnecke, and P. Sperling Identification and Functional Characterization of the 2-Hydroxy Fatty N-Acyl-{Delta}3(E)-desaturase from Fusarium graminearum J. Biol. Chem., December 26, 2008; 283(52): 36734 - 36742. [Abstract] [Full Text] [PDF]

				T. Oura and S. Kajiwara Disruption of the sphingolipid {Delta}8-desaturase gene causes a delay in morphological changes in Candida albicans Microbiology, December 1, 2008; 154(12): 3795 - 3803. [Abstract] [Full Text] [PDF]

				P. M. Tavares, K. Thevissen, B. P. A. Cammue, I. E. J. A. Francois, E. Barreto-Bergter, C. P. Taborda, A. F. Marques, M. L. Rodrigues, and L. Nimrichter In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4522 - 4525. [Abstract] [Full Text] [PDF]

				N. S. Plesofsky, S. B. Levery, S. A. Castle, and R. Brambl Stress-Induced Cell Death Is Mediated by Ceramide Synthesis in Neurospora crassa Eukaryot. Cell, December 1, 2008; 7(12): 2147 - 2159. [Abstract] [Full Text] [PDF]

				N. L. van der Weerden, F. T. Lay, and M. A. Anderson The Plant Defensin, NaD1, Enters the Cytoplasm of Fusarium Oxysporum Hyphae J. Biol. Chem., May 23, 2008; 283(21): 14445 - 14452. [Abstract] [Full Text] [PDF]

				M. L. Rodrigues, L. Shi, E. Barreto-Bergter, L. Nimrichter, S. E. Farias, E. G. Rodrigues, L. R. Travassos, and J. D. Nosanchuk Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against Lethal Cryptococcus neoformans Infection Clin. Vaccine Immunol., October 1, 2007; 14(10): 1372 - 1376. [Abstract] [Full Text] [PDF]

				R. Rhome, T. McQuiston, T. Kechichian, A. Bielawska, M. Hennig, M. Drago, G. Morace, C. Luberto, and M. Del Poeta Biosynthesis and Immunogenicity of Glucosylceramide in Cryptococcus neoformans and Other Human Pathogens Eukaryot. Cell, October 1, 2007; 6(10): 1715 - 1726. [Full Text] [PDF]

				A. Zakrzewska, A. Boorsma, D. Delneri, S. Brul, S. G. Oliver, and F. M. Klis Cellular Processes and Pathways That Protect Saccharomyces cerevisiae Cells against the Plasma Membrane-Perturbing Compound Chitosan Eukaryot. Cell, April 1, 2007; 6(4): 600 - 608. [Abstract] [Full Text] [PDF]

				M. L. Rodrigues, L. Nimrichter, D. L. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport Eukaryot. Cell, January 1, 2007; 6(1): 48 - 59. [Abstract] [Full Text] [PDF]

				P. Ternes, P. Sperling, S. Albrecht, S. Franke, J. M. Cregg, D. Warnecke, and E. Heinz Identification of Fungal Sphingolipid C9-methyltransferases by Phylogenetic Profiling J. Biol. Chem., March 3, 2006; 281(9): 5582 - 5592. [Abstract] [Full Text] [PDF]

				L. J. Heung, C. Luberto, and M. Del Poeta Role of Sphingolipids in Microbial Pathogenesis Infect. Immun., January 1, 2006; 74(1): 28 - 39. [Full Text] [PDF]

				S. Vylkova, X. S. Li, J. C. Berner, and M. Edgerton Distinct Antifungal Mechanisms: {beta}-Defensins Require Candida albicans Ssa1 Protein, while Trk1p Mediates Activity of Cysteine-Free Cationic Peptides Antimicrob. Agents Chemother., January 1, 2006; 50(1): 324 - 331. [Abstract] [Full Text] [PDF]

				L. Nimrichter, M. D. Cerqueira, E. A. Leitao, K. Miranda, E. S. Nakayasu, S. R. Almeida, I. C. Almeida, C. S. Alviano, E. Barreto-Bergter, and M. L. Rodrigues Structure, Cellular Distribution, Antigenicity, and Biological Functions of Fonsecaea pedrosoi Ceramide Monohexosides Infect. Immun., December 1, 2005; 73(12): 7860 - 7868. [Abstract] [Full Text] [PDF]

				Z. Feng, B. Jiang, J. Chandra, M. Ghannoum, S. Nelson, and A. Weinberg Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans Journal of Dental Research, May 1, 2005; 84(5): 445 - 450. [Abstract] [Full Text] [PDF]

				A. Zakrzewska, A. Boorsma, S. Brul, K. J. Hellingwerf, and F. M. Klis Transcriptional Response of Saccharomyces cerevisiae to the Plasma Membrane-Perturbing Compound Chitosan Eukaryot. Cell, April 1, 2005; 4(4): 703 - 715. [Abstract] [Full Text] [PDF]

				C. Park, B. Bennion, I. E. J. A. Francois, K. K. A. Ferket, B. P. A. Cammue, K. Thevissen, and S. B. Levery Neutral glycolipids of the filamentous fungus Neurospora crassa: altered expression in plant defensin-resistant mutants J. Lipid Res., April 1, 2005; 46(4): 759 - 768. [Abstract] [Full Text] [PDF]

				R. G. Spelbrink, N. Dilmac, A. Allen, T. J. Smith, D. M. Shah, and G. H. Hockerman Differential Antifungal and Calcium Channel-Blocking Activity among Structurally Related Plant Defensins Plant Physiology, August 1, 2004; 135(4): 2055 - 2067. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 279/6/3900    most recent M311165200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thevissen, K. Articles by Cammue, B. P. A. Search for Related Content PubMed PubMed Citation Articles by Thevissen, K. Articles by Cammue, B. P. A. Social Bookmarking                      What's this?